Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Heron Therapeutics Q3 2024 Earnings Preview Nov. 10, 2024 5:35 PM ET By: Pranav Ghumatkar , SA News Editor [Seeking Alpha]

Heron Therapeutics, Inc. (HRTX) 
Last heron therapeutics, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: herontherapeutics.gcs-web.com/investor-home
Company Research Source: Seeking Alpha
The consensus EPS Estimate is -$0.04 (+76.5% Y/Y) and the consensus Revenue Estimate is $36.93M (+17.5% Y/Y). Over the last 2 years, HRTX has beaten EPS estimates 50% of the time and has beaten revenue estimates 63% of the time. More on Heron Therapeutics Heron Therapeutics: Zynrelef Developments Are Unlikely To Provide Relief To Investors Heron gains on FDA nod for new Zynrelef application Seeking Alpha's Quant Rating on Heron Therapeutics Historical earnings data for Heron Therapeutics Financial information for Heron Therapeutics Recommended For You Comments More Trending News Show less Read more
Impact Snapshot
Event Time:
HRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
HRTX alerts

from News Quantified
Opt-in for
HRTX alerts

from News Quantified